Core Insights - Hawkins, Inc. will participate in the Raymond James & Associates' 47th Annual Institutional Investors Conference on March 3 and 4, 2026, in Orlando, Florida, with CEO Patrick Hawkins and CFO Jeff Oldenkamp attending [1][3]. Company Overview - Hawkins, Inc. is a leading water treatment and specialty ingredients company, founded in 1938, headquartered in Roseville, Minnesota, and operates 65 facilities across 28 states [4]. - The company generated $974 million in revenue for fiscal 2025 and employs approximately 1,100 people [4]. Conference Details - The Raymond James Institutional Investors Conference serves as a platform for portfolio managers to explore investment opportunities across various industries, with the 2025 conference attracting around 2,000 attendees from nearly 900 institutional investment firms [2]. - The 2026 conference will feature presentations from senior management teams of approximately 300 companies, providing insights into both the companies and their respective industry sectors [2].

经济观察网根据公开信息，霍金斯材料(HWKN.US)近期值得关注的事件主要围绕其财务表现和战略动 向。 业绩经营情况 2026年1月29日，公司发布了2025财年第四季度及全年业绩。第四季度营收为2.44亿美元，同比增长 7.9%；但归母净利润为0.14亿美元，同比下滑4.7%。业绩的主要驱动力来自水处理部门，其销售额同比 增长20.8%；而食品与健康科学部门销售额则同比下降9.9%。 公司在本季度宣布派发每股0.19美元的现金股息，较去年同期有所增加，体现了其稳定的股息政策。 未来发展 在财报中，公司对2027财年作出展望，预计将回归历史性的有机收入增长率，并继续执行通过收购实现 增长的战略。同时，公司提示食品终端市场在下一季度可能继续面临定价压力。截至2026年2月18日， 公开资料中未提及近期(如未来一周)有新的财报发布或重大事件公告。 以上内容基于公开资料整理，不构成投资建议。 战略推进 公司在2025财年完成了多次收购，包括对WaterSurplus和Redbird Chemical的收购，这些活动显著推动了 收入增长，但也带来了额外的摊销和利息费用，对短期利润造成压力。公司预计，与WaterSur ...

Group 1 - The core event of interest for Hawkins Materials (HWKN.us) is based on its recent stock price movement and fundamental data [1] Group 2 - The stock price surged by 5.16%, closing at $152.78 per share, with a trading volume of 51,964 shares, a turnover rate of 0.25%, and a fluctuation of 5.14%. The overall chemical products industry had a gain of 0.34% during the same period, which may have indirectly influenced the company's performance [2] Group 3 - Financial performance shows that the company reported revenue of $280 million, a net profit of $22.6 million, and earnings per share of $1.09, with a price-to-earnings ratio of 38.41 [3] Group 4 - Institutional ratings indicate that 67% of brokers recommend a buy, while 33% suggest holding, with no sell recommendations. There are currently no specific upcoming events mentioned for Hawkins Materials after February 13, 2026, such as earnings releases or major announcements [4]

Core Viewpoint - Hawkins Materials (HWKN.us) experienced a significant stock price increase of 5.16%, closing at $152.78 per share, influenced by its latest financial results and overall industry performance [1]. Stock Performance - The company's stock price showed notable growth with a trading volume of 51,964 shares, a turnover rate of 0.25%, and a price fluctuation of 5.14% on the day [2]. Financial Performance - According to the latest financial report, the company reported revenue of $280 million, a net profit of $22.6 million, and earnings per share of $1.09, with a price-to-earnings ratio of 38.41 [3]. Analyst Ratings - Current analyst ratings indicate that 67% of brokers recommend a buy, while 33% suggest holding, with no sell recommendations present [4]. Industry Environment - The chemical products industry saw an overall increase of 0.34% during the same period, which may have indirectly influenced the company's performance [5].

Core Insights - Hawkins, Inc. has successfully completed a multi-year pilot test of WaterSurplus' NanoStack™ coated membranes at the Orange County Water District's Groundwater Replenishment System [1][2] Group 1: Technology and Implementation - Based on the pilot's success, OCWD will install 1,050 NanoStack™ coated membranes, which will treat approximately 5 million gallons of water per day for indirect potable reuse [2] - The NanoStack™ technology has shown significant improvements in fouling resistance, reducing clean-in-place requirements by over 50% and lowering reverse osmosis energy consumption by more than 15% [2] - The estimated payback period for the investment in NanoStack™ technology is less than two years due to the savings in energy costs, which are a major operating expense for advanced water treatment facilities [2] Group 2: Product Details - NanoStack™ is an NSF/ANSI/CAN 61-certified hydrophilic membrane surface modification that enhances the durability and performance of reverse osmosis membrane elements [3] - This advanced coating helps customers achieve more reliable long-term operation with lower lifecycle costs [3] Group 3: Company Overview - Hawkins, Inc. was founded in 1938 and specializes in water treatment and specialty ingredients, serving various sectors including Water Treatment, Food & Health Sciences, and Industrial Solutions [4] - The company is headquartered in Roseville, Minnesota, operates 65 facilities across 28 states, and generated $974 million in revenue for fiscal 2025 [4]

Core Insights - Giverny Capital Asset Management's portfolio returned 0.01% in Q4 2025, underperforming the S&P 500's 2.66% return, and year-to-date returns were 12.58% compared to the index's 17.88% [1] - The firm faced challenges due to the outperformance of large technology companies, which negatively impacted the portfolio's performance due to its underweight in large tech and overweight in smaller niche leaders [1] - Despite strong earnings growth and capital returns from portfolio companies, the market's focus on AI investments has created uncertainty regarding actual benefits [1] Company Highlights - Hawkins, Inc. (NASDAQ:HWKN) was highlighted as a new holding in Giverny Capital Asset Management's Q4 2025 investor letter [2] - Hawkins, Inc. specializes in manufacturing ingredients for water treatment, food and health applications, and industrial use, with a market capitalization of approximately $2.722 billion [2] - The stock closed at $130.25 per share on January 30, 2026, with a one-month return of 13.20% and a twelve-month gain of 15.77% [2] - The company was closely monitored by Giverny Capital, with management visits conducted in the summer of 2024, and a price correction in fall 2025 provided an opportunity for investment [3]

分组1 - Hawkins reported quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.75 per share, representing an earnings surprise of -3.36% [1] - The company posted revenues of $244.08 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 3.71%, compared to year-ago revenues of $226.21 million [2] - Over the last four quarters, Hawkins has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] 分组2 - The current consensus EPS estimate for the coming quarter is $0.78 on revenues of $264.47 million, and for the current fiscal year, it is $4.04 on revenues of $1.09 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 23% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Hawkins' stock performance [5]

Sales Performance - Sales for the three months ended December 28, 2025, were $244.1 million, an increase of $17.9 million, or 8%, compared to $226.2 million in the same period a year ago[74]. - Sales for the nine months ended December 28, 2025, were $817.8 million, an increase of $88.7 million, or 12%, from $729.1 million in the same period a year ago[88]. - Water Treatment segment sales increased by $20.7 million, or 21%, to $120.5 million for the three months ended December 28, 2025, driven by approximately $19 million from acquired businesses[75]. - Water Treatment segment sales for the nine months ended December 28, 2025, increased by $79.5 million, or 23%, to $421.0 million, with approximately $70 million from acquired businesses[89]. - Industrial Solutions segment sales increased by $11.3 million, or 7%, to $164.7 million for the nine months ended December 28, 2025[91]. - Food & Health Sciences segment sales decreased by $7.7 million, or 10%, to $70.0 million for the three months ended December 28, 2025, primarily due to decreased volumes[76]. Profitability - Gross profit for the three months ended December 28, 2025, increased by $2.4 million, or 5%, to $50.8 million, representing 21% of sales[79]. - Gross profit increased by $17.5 million, or 10%, to $190.8 million, representing 23% of sales for the nine months ended December 28, 2025[92]. - Water Treatment segment gross profit rose by $19.6 million, or 20%, to $116.6 million, maintaining 28% of sales for the same period[93]. - Food & Health Sciences segment gross profit decreased by $3.6 million, or 7%, to $48.7 million, accounting for 21% of sales[94]. - Operating income for the three months ended December 28, 2025, increased by $1.5 million, or 7%, to $22.6 million, or 9% of sales[84]. - Operating income increased by $3.2 million, or 3%, to $97.8 million, which is 12% of sales[97]. Expenses and Interest - SG&A expenses increased by $14.3 million, or 18%, to $93.0 million, representing 11% of sales[96]. - Interest expense increased to $3.4 million for the three months ended December 28, 2025, compared to $1.2 million in the same period a year ago, due to increased borrowings[85]. - Interest expense rose by $6.6 million to $10.5 million due to increased borrowings for the acquisition of WaterSurplus[98]. Cash Flow - Cash provided by operating activities was $106.6 million, up from $80.3 million in the same period last year[102]. - Cash used in investing activities was $204.6 million, including $167.1 million for acquisitions, primarily WaterSurplus[103]. - Cash provided by financing activities was $101.1 million, with net debt borrowings of $115.0 million[104]. - The effective interest rate on borrowings was 4.8% as of December 28, 2025[109]. Segment Reporting - The company realigned its reporting segments to Water Treatment, Food & Health Sciences, and Industrial Solutions to better reflect its operations[69].

Core Insights - Hawkins, Inc. reported record results in revenue, gross profit, operating income, and Adjusted EBITDA for the third quarter of fiscal 2026, driven by acquisition activity in the Water Treatment segment and improvements in the Industrial Solutions segment [3][5]. Financial Performance - Revenue for the third quarter reached $244.1 million, an increase of 8% from $226.2 million in the same period last year, with Water Treatment segment growth of 21% and Industrial Solutions segment growth of 10% [5][7]. - Gross profit increased by 5% to $50.8 million, maintaining a gross margin of 21% [5][11]. - Adjusted EBITDA was $34.8 million, a 3% increase from the previous year, with a trailing 12-month Adjusted EBITDA of $179 million [5][17]. Earnings and Expenses - Diluted earnings per share (EPS) were $0.69, a decrease of 4% due to increased amortization and interest expenses related to acquisitions [5][6]. - Selling, general, and administrative (SG&A) expenses rose by 3% to $28.3 million, accounting for 12% of sales, influenced by costs from acquired businesses [15]. Segment Performance - The Water Treatment segment reported sales of $120.5 million, up 21% from $99.8 million, attributed to $19 million from acquired businesses and improved pricing [8]. - The Food & Health Sciences segment saw a decline in sales by 10% to $70.0 million, primarily due to decreased sales volumes [9]. - The Industrial Solutions segment's sales increased by 10% to $53.6 million, driven by higher sales of manufactured products [10]. Cash Flow and Debt Management - Operating cash flow for the quarter was $35 million, with $15 million used to pay down debt, resulting in a leverage ratio of 1.47x Adjusted EBITDA [5][19]. - Total debt outstanding at the end of the quarter was $264 million, reflecting a strategic focus on reducing leverage [19]. Future Outlook - The company anticipates continued pricing pressures in the Food and Health Sciences segment but expects to return to historical organic revenue growth rates in fiscal 2027 [3].

Published: January 2026 1 FISCAL 2026 Q3 INVESTOR PRESENTATION FORWARD-LOOKING STATEMENTS © 2026 Hawkins, Inc. The information contained in this presentation includes "forward-looking statements" which reflect management's expectations or beliefs as of the date of this presentation. Hawkins, Inc. cautions that actual future results could differ materially from the forward-looking statements in this presentation. Actual results may be affected by many important factors including risks and uncertainties ident ...